{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:42:48Z","timestamp":1776958968194,"version":"3.51.4"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Diffuse alveolar hemorrhage (DAH) is a life-threatening complication of hematopoietic cellular therapy (HCT). This study aimed to evaluate the effect of DAH treatments on outcomes using data from consecutive HCT patients clinically diagnosed with DAH from 3 institutions between January 2018-August 2022. Endpoints included sustained complete response (sCR) defined as bleeding cessation without recurrent bleeding, and non-relapse mortality (NRM). Forty children developed DAH at a median of 56.5 days post-HCT (range 1-760). Thirty-five (88%) had at least one concurrent endothelial disorder, including transplant-associated thrombotic microangiopathy (n=30), sinusoidal obstructive syndrome (n=19), or acute graft versus host disease (n=10). Fifty percent had a concurrent pulmonary infection at the time of DAH. Common treatments included steroids (n=17, 25% sCR), inhaled tranexamic acid (INH TXA,n=26, 48% sCR), and inhaled recombinant activated factor VII (INH fVIIa, n=10, 73% sCR). NRM was 56% 100 days after first pulmonary bleed and 70% at 1 year. Steroid treatment was associated with increased risk of NRM (HR 2.25 95% CI 1.07-4.71, p=0.03), while treatment with INH TXA (HR 0.43, 95% CI 0.19- 0.96, p=0.04) and INH fVIIa (HR 0.22, 95% CI 0.07-0.62, p=0.005) were associated with decreased risk of NRM. Prospective studies are warranted to validate these findings.<\/jats:p>","DOI":"10.3389\/fonc.2023.1232621","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T23:37:50Z","timestamp":1689896270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Diffuse alveolar hemorrhage after hematopoietic cell transplantation- response to treatments and risk factors for mortality"],"prefix":"10.3389","volume":"13","author":[{"given":"Michelle L.","family":"Schoettler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher E.","family":"Dandoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anora","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilynn","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko M.","family":"Tarquinio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonata","family":"Jodele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muna","family":"Qayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradip","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni","family":"Petrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Obordo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine S.","family":"Higham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher C.","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrianna","family":"Westbrook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt S.","family":"Zinter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.109.5.965","article-title":"Diffuse alveolar hemorrhage in pediatric hematopoietic cell transplant patients","volume":"109","author":"Heggen","year":"2002","journal-title":"Pediatrics"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01293-y","article-title":"Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantation","volume":"56","author":"Wu","year":"2021","journal-title":"Bone Marrow Transpl"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701995","article-title":"High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients","volume":"24","author":"Raptis","year":"1999","journal-title":"Bone Marrow Transpl"},{"key":"B4","article-title":"Alveolar hemorrhage","volume-title":"Orphan lung dis a clin guid to rare lung dis","author":"Wells","year":"2014"},{"key":"B5","article-title":"Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation","volume":"15","author":"Srivastava","year":"1995","journal-title":"Bone Marrow Transpl"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2021000293","article-title":"Noninfectious complications of hematopoietic cell transplantation","volume":"2021","author":"Williams","year":"2021","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-2-145","article-title":"Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients","volume":"114","author":"Chao","year":"1991","journal-title":"Ann Intern Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(89)80606-0","article-title":"Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients","volume":"87","author":"Robbins","year":"1989","journal-title":"Am J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702546","article-title":"Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy","volume":"26","author":"Lewis","year":"2000","journal-title":"Bone Marrow Transpl"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.01.008","article-title":"Epidemiology, risk factors, and outcomes of diffuse alveolar hemorrhage after hematopoietic stem cell transplantation","volume":"159","author":"Zhang","year":"2021","journal-title":"Chest"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.11.411","article-title":"Diffuse alveolar hemorrhage (DAH) and infection associated alveolar hemorrhage (IAH) following hematopoietic stem-cell transplantation: related and high risk clinical syndromes with poor response to high-dose corticosteroids","volume":"12","author":"Majhail","year":"2006","journal-title":"Biol Blood Marrow Transpl"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101592","article-title":"Reactive species generated by heme impair alveolar epithelial sodium channel function in acute respiratory distress syndrome","volume":"36","author":"Aggarwal","year":"2020","journal-title":"Redox Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00155.2015","article-title":"Cell-free hemoglobin: a novel mediator of acute lung injury","volume":"310","author":"Shaver","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.96910","article-title":"Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles","volume":"3","author":"Merle","year":"2018","journal-title":"JCI Insight"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.09.026","article-title":"Inhaled tranexamic acid for hemoptysis treatment: a randomized controlled trial","volume":"154","author":"Wand","year":"2018","journal-title":"Chest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000075","article-title":"Inhaled tranexamic acid as a novel treatment for pulmonary hemorrhage in critically ill pediatric patients: an observational study","volume":"2","author":"O\u2019Neil","year":"2020","journal-title":"Crit Care Explor"},{"key":"B17","doi-asserted-by":"publisher","first-page":"R177","DOI":"10.1186\/cc5132","article-title":"Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage","volume":"10","author":"Heslet","year":"2006","journal-title":"Crit Care"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-1782","article-title":"Intrapulmonary recombinant factor VIIa for diffuse alveolar hemorrhage in children","volume":"135","author":"Park","year":"2015","journal-title":"Pediatrics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.01.070","article-title":"Recombinant factor VIIa to treat diffuse alveolar hemorrhage following allogeneic stem cell transplantation","volume":"13","author":"Shenoy","year":"2007","journal-title":"Biol Blood Marrow Transpl"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2015.231","article-title":"Pilot trial of a novel two-step therapy protocol using nebulized tranexamic acid and recombinant factor VIIa in children with intractable diffuse alveolar hemorrhage","volume":"35","author":"Bafaqih","year":"2015","journal-title":"Ann Saudi Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2016.59.3.105","article-title":"Diffuse alveolar hemorrhage and recombinant factor VIIa treatment in pediatric patients","volume":"59","author":"Park","year":"2016","journal-title":"Korean J Pediatr"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy802","article-title":"Pulmonary metagenomic sequencing suggests missed infections in immunocompromised children","volume":"68","author":"Zinter","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.02.009","article-title":"Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial","volume":"16","author":"Richardson","year":"2010","journal-title":"Biol Blood Marrow Transpl"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01644-3","article-title":"Diffuse alveolar hemorrhage: an underreported complication of transplant associated thrombotic microangiopathy","volume":"57","author":"Agarwal","year":"2022","journal-title":"Bone Marrow Transpl"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-6367(23)00089-1","article-title":"Prospective study of allogeneic pediatric transplant associated thrombotic microangiopathy- novel prognostic markers, biologic interaction and poor response to eculizumab","author":"Schoettler","year":"2023","journal-title":"Transpl Cell Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2012.08.022","article-title":"Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"19","author":"Jodele","year":"2013","journal-title":"Biol Blood Marrow Transpl"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0159-8","article-title":"High-dose Carboplatin\/Etoposide\/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma","volume":"53","author":"Jodele","year":"2018","journal-title":"Bone Marrow Transpl"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/J.BBMT.2018.12.840","article-title":"Thrombotic microangiopathy following pediatric autologous hematopoietic cell transplantation: a report of significant end-organ dysfunction in eculizumab-treated survivors","volume":"25","author":"Schoettler","year":"","journal-title":"Biol Blood Marrow Transplant"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.06.006","article-title":"Risk factors for transplant-associated thrombotic microangiopathy after autologous hematopoietic cell transplant in high-risk neuroblastoma","volume":"25","author":"Tolbert","year":"2019","journal-title":"Biol Blood Marrow Transpl"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.315595","article-title":"Vascular endothelial damage in the pathogenesis of organ injury in severe COVID-19","volume":"41","author":"Dupont","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/bloodadvances.2020003455","article-title":"A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant","volume":"5","author":"Dandoy","year":"2020","journal-title":"Blood Adv"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.06.004","article-title":"Pulmonary complications in pediatric and adolescent patients following allogeneic hematopoietic cell transplantation","volume":"25","author":"Broglie","year":"2019","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1232621\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T23:37:54Z","timestamp":1689896274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1232621\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":32,"alternative-id":["10.3389\/fonc.2023.1232621"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1232621","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"article-number":"1232621"}}